IBRX Immunitybio Inc
Company Analysis
Latest News
🔴 Immunitybio is trading 5.3% down; reason remains unclear
Immunitybio is trading at $9.59, down 5.29%, and the reason for the October 13 decline remains unclear. - No clear company-specific announcement or event...
🔴 Immunitybio is trading 4% down
Immunitybio is trading at $10.09, down 4.04% in the live session on October 12, 2026; no clear company-specific catalyst was identified. - Major indices were...
🟢 Immunitybio is trading 5% up — no clear catalyst identified
Immunitybio is trading at $10.40, up +4.99%, during the October 9, 2026 session, with no clear company-specific catalyst identified for the gain. -...
🔴 Immunitybio is trading 4.19% down as biotech shares come under pressure
Immunitybio is trading 4.19% down at $9.95 now, with biotech weakness the clearest available context for the decline. - No clear company-specific explanation...
🟢 Immunitybio is trading 10% up today with broader markets higher; catalyst remains unclear
Immunitybio is trading 10.05% higher at $10.21, with no clear company-specific announcement explaining the October 2 move. - The company is scheduled to...
🟢 Immunitybio is trading 7% up today amid broader market gains
Immunitybio is trading at $9.89, up 6.63%, amid broader market strength. - No clear company-specific announcement explaining the rise surfaced in the...
🟢 Immunitybio is trading 11% up with no clear company-specific catalyst identified
Immunitybio is trading at $9.79, up +10.82%, with no clear company-specific announcement identified to explain its September 30 move. - Recent coverage...
🟢 Immunitybio is trading 5.4% up
Immunitybio is trading at $9.31, up +5.44%, while the reason for the September 30 move remains unclear. - No clear company-specific announcement explaining...
🟢 Immunitybio is trading 4.11% up
Immunitybio is trading 4.11% higher now at $8.87 on September 29, 2026, with no clear company-specific catalyst identified. - Recent coverage has focused on...
🟢 Immunitybio is trading 4.3% up
Immunitybio is trading at $8.80, up +4.32%, on September 28, 2026, with no clear company-specific announcement identified to explain the gain. - Recent...
ImmunityBio Rallies Nearly 10% on Turkey Expansion Plans
ImmunityBio founder Dr. Patrick Soon-Shiong met with Turkish President Recep Tayyip Erdogan to discuss the company’s planned expansion into Turkey’s cancer...
🔴 Immunitybio is trading 4.38% down today while biotech sector gains
Immunitybio is trading 4.38% down at $8.88, with no new company announcement or confirmed fundamental catalyst clearly explaining the September 23 decline. -...
🟢 Immunitybio is trading 10.71% up today amid intensified retail speculation over Nant's blockchain plans
Immunitybio is trading at $9.36, up +10.71%, as retail speculation intensifies around Nant’s planned blockchain and tokenized-stock platform. - No confirmed...
🟢 Immunitybio is trading 4.44% up today amid retail speculation over Nant’s blockchain plans
Immunitybio is trading $8.82 (+4.44%) amid retail speculation following Patrick Soon-Shiong’s discussion of Nant’s planned blockchain and tokenized-stock...
🟢 Immunitybio is trading 10.18% up today as biotech shares rally after Fed decision
Immunitybio is trading 10.18% up at $8.71 as biotechnology shares and broader markets rally after the September 16, 2026 Federal Reserve decision. - The...
🟢 Immunitybio is trading 6% up today as markets rally after September 16 rate decision
Immunitybio is trading 6% up now at $8.38 as biotechnology stocks and broader markets rally on improved risk appetite following the Federal Reserve’s September...
🔴 Immunitybio is trading 4.12% down today as biotech stocks weaken broadly
Immunitybio is trading 4.12% down at $7.80 as biotechnology stocks weaken broadly. - The sector is down 2.11%; elevated Treasury yields, oil prices, and...
🔴 Immunitybio is trading 4.2% down today as biotech sector drops 2.11%
Immunitybio is trading 4.2% down at $8.02 as biotechnology stocks weaken alongside broader market pressure from elevated Treasury yields, oil prices, and...
🟢 Immunitybio is trading 5.2% up
Immunitybio is trading at $8.32, up 5.2% from a comparison close of $7.91 during regular trading. This is a price-action follow-up, so a separate catalyst may...
🟢 Immunitybio is trading 4.17% up today with no clear company-specific explanation
Immunitybio is trading at $8.24, up 4.17%, with no clear company-specific announcement explaining the September 14, 2026 gain. - Immunitybio is appearing at...